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Embedding qualitative research in
randomised controlled trials to improve
recruitment: findings from two recruitment
optimisation studies of orthopaedic surgical
trials
Arabella Scantlebury1* , Catriona McDaid1, Stephen Brealey1, Elizabeth Cook1, Hemant Sharma2,
Arun Ranganathan3, Joy Adamson1 and on behalf of the ACTIVE and PRESTO study teams
Abstract
Background: Recruitment of patients is one of the main challenges when designing and conducting randomised
controlled trials (RCTs). Trials of rare injuries or those that include surgical interventions pose added challenges due
to the small number of potentially eligible patients and issues with patient preferences and surgeon equipoise. We
explore key issues to consider when recruiting to orthopaedic surgical trials from the perspective of staff and
patients with the aim of informing the development of strategies to improve recruitment in future research.
Design: Two qualitative process evaluations of a UK-wide orthopaedic surgical RCT (ACTIVE) and mixed methods
randomised feasibility study (PRESTO). Qualitative semi-structured interviews were conducted and data was analysed
thematically.
Setting: NHS secondary care organisations throughout the UK. Interviews were undertaken via telephone.
Participants: Thirty-seven health professionals including UK-based spinal and orthopaedic surgeons and individuals
involved in recruitment to the ACTIVE and PRESTO studies (e.g. research nurses, surgeons, physiotherapists). Twenty-
two patients including patients who agreed to participate in the ACTIVE and PRESTO studies (n=15) and patients
that declined participation in the ACTIVE study (n=7) were interviewed.
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Results: We used a mixed methods systematic review of recruiting patients to randomised controlled trials as a
framework for reporting and analysing our findings. Our findings mapped onto those identified in the systematic
review and highlighted the importance of equipoise, randomisation, communication, patient’s circumstances,
altruism and trust in clinical and research teams. Our findings also emphasised the importance of considering how
eligibility criteria are operationalised and the impact of complex patient pathways when recruiting to surgical trials.
In particular, the influence of health professionals, who are not involved in trial recruitment, on patients’ treatment
preferences by suggesting they would receive a certain treatment ahead of recruitment consultations should not be
underestimated.
Conclusions: A wealth of evidence exploring factors affecting recruitment to randomised controlled trials exists. A
methodological shift is now required to ensure that this evidence is used by all those involved in recruitment and
to ensure that existing knowledge is translated into methods for optimising recruitment to future trials.
Trial registration: ACTIVE: (ISRCTN98152560). Registered on 06/03/2018. PRESTO: (ISRCTN12094890). Registered on
22/02/2018,
Keywords: Process evaluation, Recruitment, Retention, Randomised controlled trial, Orthopaedic, Surgery,
Qualitative
Background
Participant recruitment is a key challenge for randomised
controlled trials (RCTs). Failing to reach recruitment tar-
gets can have significant cost implications if funding is
stopped or extensions are required and trials that do not
recruit to target are underpowered to detect an effect
[1]. Trials of surgical interventions, especially those that
compare surgical and non-surgical interventions face re-
cruitment challenges, due to the irreversibility of surgical
treatments and issues with surgeon equipoise [2–5]. The
stakes are particularly high for trials of rare fractures or
injuries, where there are a limited number of eligible pa-
tients and so there is an added impetus to recruit as
many eligible patients as possible.
There is growing evidence on the barriers and facilita-
tors to surgical trial recruitment [3, 6]. A mixed methods
systematic review synthesised the evidence on recruit-
ment to surgical trials from the patient perspective [1].
The review, which included 34 papers (11 quantitative
and 21 qualitative), concluded that whether a patient
chooses to participate or not in a RCT is influenced by
multiple inter-related factors such as patients’ perceptions
of the risk and benefits of participation and their treatment
preferences. The authors recommended that future trials
consider a patient-centred approach to trial recruitment
that tailors information to the individual patient. For re-
cruitment to be effective, it is also important to take stock
of staff’s experiences of recruitment to ensure that future
strategies for improving recruitment consider not only
what is important to patients, but the practicalities of
recruiting patients in a complex healthcare system [1].
We present the findings of two qualitative process evalu-
ations undertaken during the PRESTO (Pragmatic Rando-
mised Evaluation of Stable Thoracolumbar fracture
Treatment Outcomes) feasibility study [7] and ACTIVE
(Articular type C pilon fracture Trial comparing Internal
Versus External fixation) trial’s internal pilot. The main a
priori research question for both process evaluations was
how to best optimise recruitment by exploring patients,
surgeons and local recruiting staffs’ views and experiences
of the interventions and trial processes. In this paper, we
draw on the work of Phelps et al. [1] and use the findings
from our two process evaluations to highlight how recruit-
ment to future orthopaedic RCTs may be improved from
the perspective of trial recruiters and patients.
Methods
Design
Two qualitative evaluations of orthopaedic surgical trials
were undertaken and consisted of interviews with patients
who agreed to take part in the ACTIVE or PRESTO stud-
ies, interviews with patients who declined participation
and interviews with ACTIVE and PRESTO trial recruiters
(surgeons, physiotherapists, research nurses). Interviews
with surgeons from across the UK (who were not part of
recruiting teams) were conducted during PRESTO as one
of the main aims of the study was to understand the
current treatment of stable thoracolumbar fractures. Data
collection took place during the PRESTO study’s 12-
month recruitment phase and the ACTIVE study’s 12-
month internal pilot recruitment phase (Table 1).
Sampling and recruitment
To obtain maximum variation, we sought to purposively
sample patients on the basis of age, gender, recruitment
site and treatment received. Given the lower than antici-
pated recruitment to the main PRESTO and ACTIVE
studies and process evaluations, we adopted a conveni-
ence sampling frame with selection based on those who
agreed to interview. In both studies, all patients,
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irrespective of whether they agreed to participate in the
trial were invited to take part in the qualitative study and
were provided with a separate participant information
sheet and consent form. A contact details form was also
completed and transferred to the qualitative team for
those that declined to participate in the ACTIVE or
PRESTO studies. Informed consent was obtained prior
to each interview.
For the ACTIVE trial, initially, we aimed to only inter-
view staff who had been directly involved in recruiting
patients. Due to the staggered opening of sites and lower
than anticipated recruitment of patients, we also invited
staff at sites open for, but just prior to recruitment. AC-
TIVE trial recruiters were invited to interview via email.
For PRESTO, trial recruiters from the 3 participat-
ing sites were interviewed. In addition, snowballing
techniques were used to ensure that a wide range of
surgeons from across the UK were interviewed. This
approach is appropriate when the number of experts
in the field is relatively small and so many surgeons
are known to each other [8]. However, we utilised a
range of additional recruitment strategies to ensure
interviewees represented a range of geographical loca-
tions, specialties (orthopaedics, neurosurgeons) and
grades (consultants, registrars). We asked clinical co-
applicants to forward recruitment emails to surgical
colleagues, both in and outside of PRESTO sites; ad-
vertised for participants through the British Associ-
ation of Spine Surgeons (BASS) newsletter and
through a regional network of spinal surgeons; and by
sending an invitation email to those who expressed an
interest in the qualitative study through the PRESTO
survey (n=19).
Participants
Thirty-seven surgeons and trial recruiters (research
nurses, research physios) were interviewed during the
PRESTO (n=19) and ACTIVE (n=18) process evalua-
tions. Surgeons across both studies represented differ-
ent grades (registrars and consultants) and specialties
(orthopaedics, neurosurgery). Additionally, 15 patients
who agreed to take part in the PRESTO (n=5) and
ACTIVE (n=10) process evaluations were interviewed.
ACTIVE interviewees represented a range of genders
and treatment allocations. However, all but one of the
PRESTO patient interviewees were male and received
surgical fixation. Interviews were conducted with 7
patients that declined to participate in the ACTIVE
trial, no patients that declined to participate in PRES
TO were interviewed.
Semi-structured interviews with patients, surgeons and
trial recruiters
All interviews were semi-structured, were conducted via
telephone and followed topic guides that were developed
by the research team and clinical co-applicants. Inter-
viewees were asked a range of questions, which aimed to
explore how patients were approached to take part in
the two studies, trial procedures and current treatment.
Further details of the topics covered during interviews
can be found in Additional files 1, 2, 3, 4, 5 and 6.
Table 1 ACTIVE and PRESTO study details
ACTIVE PRESTO
Objectives To investigate the clinical and cost-effectiveness of internal plate
fixation versus external fine wire fixation for the management of
type C pilon fractures of the distal tibia.
To establish whether it is feasible to deliver a trial comparing
surgical fixation to initial non-surgical management for patients
with a stable thoracolumbar fracture without spinal cord injury.
Design Parallel randomised controlled trial. A 12-month internal pilot with
associated qualitative study to assess recruitment and provide
guidance on optimising trial processes.
A feasibility study consisting of three elements: a randomised




Arm 1: Internal fixation: ‘Locking’ plate fixation with screws.
Arm 2: External frame fixation: limited open reduction and
articular fixation using screws and fine wire fixator.
Arm 1: Surgical fixation. Either open spinal surgery or minimally
invasive surgery as per current UK surgical treatment.
Arm 2: Non-surgical management. Mobilisation in a brace or mo-
bilisation without a brace.
Primary
outcome





Ongoing (ISRCTN98152560) Completed (ISRCTN12094890)
Ethical
approval
Approved by Yorkshire and The Humber – Bradford Leeds REC on
13th February 2018 (REC reference 18/YH/0014).
Approved by North East – Newcastle and North Tyneside Research
Ethics Committee (REC) on 20th March 2018 (REC reference 18/NE/
0008).
Funder NIHR Health Technology Assessment Programme (HTA 15/130/84) NIHR Health Technology Assessment Programme (HTA 15/154/07)
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Analysis
Data collection and analysis were undertaken by AS, a
health services researcher with no clinical training or
prior experience of research in orthopaedic surgery. All
interviews and consultation recordings were audio-
recorded and transcribed verbatim. For both studies, an
initial thematic analysis was undertaken of all interviews
and consultation recordings for each individual study [9].
Themes were largely deductive and derived from study
topic guides, whilst also allowing for emergent themes.
Analyses for both studies was also influenced by ‘initial im-
pressions’ which were recorded immediately in an excel
spreadsheet and involved documenting key issues under a
priori headings that were devised by the research team,
topic guide and clinical co-applicants. Documenting initial
impressions allowed for early familiarisation and prelimin-
ary coding of our data and provided a mechanism for
highlighting key issues with recruitment to the Trial Man-
agement Group and recruitment sites throughout data col-
lection. A secondary analysis was then conducted where
the findings from both studies were mapped onto the
themes identified in Phelps’ systematic review [1], with
particular attention given to identifying themes relating to
optimising recruitment.
Results
First, we present the findings of both studies according
to the three main themes that were identified by Phelps
et al.’s [1] as influencing recruitment and retention to
surgical trials—making sense, weighing up and trust.
Given the significant amount of evidence that already ex-
ists around these themes [1, 10–15], we present our find-
ings using summary tables to highlight the key issues
that were identified during ACTIVE and PRESTO. We
then provide a descriptive account of ‘eligibility criteria’
and ‘patient pathways’, two themes that were identified
as influencing recruitment and retention during ACTIVE




For patients to agree to participate in an RCT, they first
need to ‘make sense’ of randomisation and the influence
it has on their treatment and involvement in their care
(Table 2). Randomisation was a new concept for the ma-
jority of patients, which when described using trial jar-
gon made the concept difficult to understand. In the
most part, patients recalled randomisation; however,
many had undergone significant trauma and so were
heavily medicated when approached to take part in the
study. As a result, patients were concerned that they
lacked capacity at the time of recruitment and felt this
restricted their ability to understand what was being
proposed and make informed decisions. However, trial
recruiters described various methods that were used dur-
ing PRESTO to ensure capacity, for example, patients
were asked to reiterate study aims before providing their
consent.
Communication
How the trial is communicated to patients is also a crit-
ical factor influencing a patient’s decision to take part in
a RCT. In both studies, the perceived quality of informa-
tion sheets, information about treatment and recovery
and when patients are approached to take part were piv-
otal to ensuring effective communication and influenced
whether patients chose to take part (Table 3).
Equipoise
Patients and trial recruiters provided various examples of
situations where equipoise had been either deliberately,
or unintentionally undermined (Table 4).
Weighing up
Patients’ decisions to participate in RCTs are under-
pinned by being in equipoise and their understanding of
randomisation. However, these decisions also require pa-
tients to trade off various perceived benefits of participa-
tion, such as altruism against treatment preferences,
personal circumstances and the perceived risks of ran-
domisation (Table 5).
Trust
If patients are to take part in a surgical trial, they need to
feel confident and have trust in their surgeon and re-
search team. When discussing how to optimise recruit-
ment, it was considered crucial by the trial team to think
about who is involved in recruitment consultations
(Table 6). Whilst there was agreement that recruitment
consultations should involve senior clinicians and the re-
search team, the practicalities of involving both teams in
large numbers of recruitment consultations were ac-
knowledged, with some sites opting for the research
team and clinicians to approach patients independently
to fit around conflicting work schedules and time
constraints.
Ensuring clinical teams are engaged throughout re-
search studies was also considered important by both
trial recruiters and patients not only for ensuring the
trust of patients but to maximise recruitment, particu-
larly in studies of rare conditions where there is pressure
to recruit every eligible patient.
Patient pathways
Patients are often admitted via complex referral pathways
and as a result, may come into contact with clinicians from
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a range of specialties, depending on the specific injury
(emergency department (ED), neurosurgery, orthopae-
dics) or from referring hospitals prior to being
approached to take part in orthopaedic surgical trials.
In PRESTO, the different ways that patients with
thoracolumbar fractures could be referred to sites was
a particular issue, with one site receiving referrals
from up to 15 hospitals. The reduced awareness of
on-going research studies, issues with equipoise and
different treatment preferences of staff that are not in-
volved in recruitment can mean that patients have
multiple conversations about the treatment they are
‘likely’ to receive before official recruitment consulta-
tions and may lead to distrust in research and trial
processes and/or patient’s being ‘biased’ towards spe-
cific treatments. The time between transfer of patients
from local hospitals to Major Trauma Centres or hubs
can mean that by the time patients are approached to
take part in a research study they may no longer meet
the eligibility criteria for the specific trial, for example
they have already started to heal and in some cases
receive non-operative treatment such as braces for
stabilisation.
We generally want to see them within a week of them
sustaining the injury and a few times it has not been
possible to arrange transport from the local hospital
up to our centre, and that has caused patients to
miss the reasonable timeframe that we would like to
follow these patients, for example if they reach five to
six weeks following the injury by the time to come to
the clinic, then it is a moot point to then discuss sur-
gical or operative options. Because conservatively
they have reached that point in their treatment,
where the fracture could have reasonable been ex-
pected to heal and we wouldn’t be doing justice to
Table 2 Key findings relating to randomisation
Randomisation
Sub-theme Description Exemplar quote
Understanding
randomisation
For most patients randomisation was a new concept “They told me it was 50/50 whether they would give me surgery,
or I would be in a brace, and it was chosen quite randomly by
the computer. No human influence on that, at all. They obviously
said that my care and everything would be exactly the same as if
I wasn’t on the trial.” (PRESTO patient interview, accepter)
Trial jargon Across both trials, staff felt patients equated randomisation to
being experimented on and to remove their choice and decision
making around treatment. Using the analogy of a toss of a coin
was considered flippant and unprofessional – ACTIVE patients
felt gambling metaphors undermined the severity of their injury
whilst trial recruiters felt that describing something as random
implies it is intrinsically bad or inferior.
Using computer-based terminology invoked fear with some pa-
tients who were reluctant to be randomised due to a mistrust in
computers and technology – patients wanted treatment to be
based on an informed choice by a qualified and experienced
person.
Clear explanations of terms such as randomisation, are more
likely to promote transparency, understanding and acceptance.
Some ACTIVE trial recruiters thought that they should not use
the word randomisation and in some cases avoided discussing
that patients would be allocated to treatments by a computer as
they were aware of the potential negative implications of this
terminology on recruitment.
“I think when you try to say randomised and talk about the
computer allocating it, people worry. It frightens people, and I
wonder if maybe my experience of that is within a study that
general has recruits who are in an older age bracket and may be
a little bit more unsure of technology and computers and want
the doctor to make their decision”. (ACTIVE Staff Interview)
“It did seem kind of not as professional. Like, “We’re going to do
this really serious thing on you”, this was serious and obviously
all operations and procedures like that, it must cost a fortune,
and for them to basically just, it was almost like it came down to
“flip the coin”” (ACTIVE Patient interview, accepter)
Recall of
randomisation
The severity of PRESTO patient’s injuries, the medication they
were prescribed and presence of other injuries led to the
capacity of these patients and whether they made informed
decisions about their treatment and trial participation to be
questioned.
Many PRESTO patients found it difficult to engage with study
materials and/or were unable to remember details of recruitment
and randomisation.
“But it probably would have been better if it was explained when
I had someone with me, because as I say, I was very sleepy. I’d
had lots of morphine, and I think I could just about keep my
eyes open when they were talking to me.” (PRESTO patient,
accepter)
PRESTO staff did not consider the patient’s capacity to be an
issue as they felt obtaining informed consent and determining
capacity during recruitment mirrored the processes used in
routine practice.
“I don’t think that (capacity is) a problem most of the time. If you
think about it, to do anything you have to get informed consent,
whether it’s a trial or not. If I operate on someone, I have to get
their consent. If I’ve discussed surgery or not surgery, implicitly
they’re consenting to have not surgery if we pursue bed rest.
Things can always change. I mean you can operate further down
the line.” (PRESTO staff interview,)
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either the patient or the trial to then discuss the two
separate options for them. (PRESTO staff interview
06)
Communication between patients and specialties or
clinicians that were not involved in trial recruitment was
thought to have caused some patients across both studies
to develop treatment preferences and view randomisa-
tion as unacceptable. Insufficient buy-in from clinical
colleagues was seen by PRESTO recruiters to exacerbate
this issue. Whilst attempts were made during PRESTO
to increase engagement of neurosurgeons through mul-
tiple departmental presentations the difficulties of asking
for a culture change ‘ahead of evidence’ was acknowl-
edged particularly given the issues with surgical equi-
poise, the comparatively low levels of research activity in
neurosurgical departments and the fact that neurosur-
geons routinely provide the perceived less resource-
intensive option of conservative management.
The neurosurgery team here are not the most helpful.
(Laughter) I don’t know whether that's because we
haven’t communicated the study very well or whether
that’s just their mentality to research. We have de-
cided that we will do a presentation to them again
to make sure that it’s not a fault on our side. You’ll
probably hear (name of staff) talk about this as well,
but we did notice a couple of the patients that we
were screening were being reviewed or presented in
A&E and then neurosurgery registrars would be going
down to review them on the request of A&E doctors.
Then they would discharge them from there, so they
weren’t getting admitted, which meant that those pa-
tients who have been told that they don’t need to be
managed with an- they essentially just get discharged
with a brace. A couple of those patients we, poten-
tially, could have included in PRESTO, but because
we missed them due to- I guess the registrars were
completely unaware of the trial. (PRESTO staff inter-
view, 10)
There were particular concerns amongst recruiters in
both trials that treatment conversations between patients
and EDs lead to patients being ‘biased’ towards a specific
treatment. In addition to undermining equipoise, one pa-
tient described how receiving a call to return to hospital to
discuss the possibility of surgery and participate in a trial
after being discharged with either no or conservative treat-
ment caused anxiety and provided a poor standard of care.
Engaging ED doctors ahead of a full trial was considered a
particular challenge given the pressure on ED to treat pa-
tients quickly to avoid affecting performance targets and
the fact that patients are often admitted ‘out of hours’
which was perceived to increase the likelihood of patients
being seen by doctors with a lower awareness of research
studies based in other departments. High staff turnover,
particularly of surgical registrars meant that Junior Doc-
tors were also considered to be prone to inadvertently
Table 3 Key findings relating to communicating research to patients
Communication
Sub-theme Description Exemplar quote
Information
sheets
Patients in both trials were generally satisfied with the written
information they received.
Some PRESTO trial recruiters thought study documentation was
appropriate, others felt the volume of information could
overwhelm patients, particularly given the nature of their
injuries.
Shortening study documents and adding links to online
information were suggested.
“I knew I was part of the trial but I really couldn’t remember
what any of the details were, so it was nice to know what I’d




In both trials, there were a number of patients that felt they did
not receive enough information about study interventions and
that information was not presented equitably. Junior doctors
were deemed unable to answer questions and consultants too
busy.
Particular emphasis was thought to have been placed on the
risks of surgery rather than on the impact of the interventions
on daily life and return to work.
Patient perceived there to be an imbalance between the time
spent discussing the trial and treatment options. PRESTO
patients in particular felt they did not receive enough
information about recovery.
“I came away thinking it was a spandex suit basically. Honestly
that’s all I knew about it. I think maybe a picture of the
potential thing you’d have to wear and also how long on
average you would probably wear these things for, like just a
bit more…yeah basic things like does it affect what you can
wear? They were definitely answered in a way by the 3
members of the team but I can’t really recall their answers so I





In both studies, participants found speaking to staff on multiple
occasions and being given time to consider their participation
and read study documentation beneficial. For one PRESTO
patient, having the time to consider their participation led to
them changing their mind and agreeing to take part.
“I said no at first. I had only just come in that day, and I was,
you know, not with it still, but then I changed my mind.” (PRES
TO patient interview, accepter)
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influencing patient expectations and be unaware of on-
going research protocols.
Unfortunately these fractures come in late at night
or early in the morning and they’re already seen by a
junior member of the team. The junior staff change
over so frequently, they’re not aware of the trial, and
they just go by…..meaning for stable fractures don’t
fix, for unstable fractures, fix, because that’s what
you’ve been taught traditionally. Once they’ve told
them in A&E that they don’t need an operation, be-
cause this trial is all about stable fractures, then it is
quite difficult to convince the patients otherwise.
(PRESTO staff interview)
Variation in current practice and strong treatment
preferences meant that the influence of ‘local logistics’,
having strict eligibility criteria and carefully considering
how to approach sites in future trials was considered
crucial. Presenting a future trial, planned protocol and
eligibility criteria at key clinical meetings was also sug-
gested as a means to secure buy-in from the clinical
community. Importance was placed on having centra-
lised centres for recruitment with it considered unfeas-
ible for referring hospitals to be involved in recruitment.
Engaging staff from other specialties at recruiting sites
was also considered important. Despite this, there were
doubts as to the feasibility and implications on time and
resources of involving multiple specialties in recruitment
to a future trial, a number of suggestions were proposed
and are displayed in Table 7.
Eligibility criteria
Difficulties operationalising eligibility criteria were re-
ported across both trials and were largely due to clinical
teams interpreting clinical criteria differently. For ex-
ample, in PRESTO, there was a lack of consensus as to
what constitutes a stable thoracolumbar fracture, whilst
Table 4 Key findings relating to equipoise
Equipoise




Emphasising that clinical teams consider both treatments to be
appropriate for the patient, are effective, routinely provided and
lead to good outcomes is important.
“The main point that we put across to the patient when we
discuss randomisation is that at the present moment, the debate
regarding the surgery or conservative options is pretty equal
among the way consultants have been practising all across the
UK. So there has been no preferred treatment for either of those
options. And that is what we were trying to find, and detailing
the options as both an equally suggestive and successful
treatment options then makes the patients more receptive to
the idea of randomisation.” (PRESTO staff interview)
Communicating
uncertainty
Disagreement as to what is considered a stable thoracolumbar
fracture, concerns that study treatments are not comparable and
the perceived inherent opinionated nature of surgeons meant
that surgeons found it difficult to discuss the uncertainty
surrounding treatment options and culminated in subtle
attempts to undermine equipoise.
PRESTO patients gave examples of surgeons expressing
preferences for the opposing treatment to what they had been
allocated post-randomisation. ACTIVE patients sensed relief, an-
noyance and disappointment from staff depending on their allo-
cation – they felt relieved when their allocation matched the
preference of the recruiter.
“I don’t think [Surgeon] was very happy because I was going
through a trial and he wanted to put the external frame on.
Then they put the plates in. […] you’re doing this trial, and he
wanted to put the cage thing on my leg. I was like, “Why
doesn’t he do it then, if he thought it was going to work
better?”[…] I can’t really remember, but he was really off with
me though”. (ACTIVE patient interview, accepter)
Remaining
neutral
In both studies, patients felt staff conveyed preferences for
specific treatments. For example, some PRESTO patients
described either not being given a choice of treatment, or
explained how after being allocated to one treatment the
surgeon stated that they would preferred them to have the
other.
Patients challenged staff neutrality by asking them what
treatment they would routinely recommend.
“My partner who was there all the time was given a choice of
having the surgery for my back or a brace and he said “No, they
said surgery.” (PRESTO patient interview, accepter)
Variation in
routine practice
In general, PRESTO surgeons were positive about the need for a
trial and saw it as crucial to address variation in practice. It was
suggested that there is a proportion of surgeons at every
hospital who would not be willing to randomise or be part of a
trial—some surgeons not involved in recruitment to PRESTO felt
it was inappropriate to ever operate on stable fractures, others
had different views.
“I don’t think there’s much variability at all for stable fractures,
except for a few places in the country, nobody operates for
these patients. If I asked everyone, except for five or six or ten
surgeons in the UK they operate for stable fractures, otherwise
people don’t operate. So those ten surgeons you can identify
first in the UK and then run the trials using those surgeons then
you can finish the trial. Otherwise you don’t want to start the
trial and then take two or three years to recruit the patients, if
you still want to run this trial.” (PRESTO staff interview)
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Table 5 Factors that patients consider when ‘weighing up’ their participation in a RCT
Weighing up
Sub-theme Description Exemplar quote
Altruism Patients valued and understood the need for clinical research
and participated for reasons such as wanting to advance
medical knowledge and/or help others.
Only a small number of staff used altruism in recruitment
consultations.
“It seemed to me that the frame was the best option and I
didn’t really want to take that risk, but then I felt bad, not bad
but – because how on earth is research going to develop if




PRESTO patients described participating to “sticking two fingers”
to family members who had strong treatment preferences and
because they thought they would receive better care if they
were part of a trial. Others seemed indifferent towards
participation and claimed ‘I’m going to be lying on my back
anyway, so what the heck’
“They were explaining to me that it would be helping other
people, but I said actually at the time I was more interested in
what was best for me, rather than what was best for other
people. But I was happy to go ahead with the trial and that I
did want an operation. And if they did come back and say
that it would have been the brace and not the operation I
would have said that I didn’t want to be part of the trial.”




Of those that declined to participate in ACTIVE many based their
decision on the perceived impact of the intervention on their
daily life. For example, the ability to mobilise and/or wear
normal clothing. Comfort, ease of commuting, positive
experiences of previous surgery and specific concerns about
compliance and the impact of the brace on daily life (PRESTO)
were cited.
“I said I would rather have the operation. I know It sounds…I
had an operation on my lower back ten years ago which was
completely different. I researched – because I’m a single dad
– I mean, my daughter’s with her other dad now who lives
abroad for her six week holiday, which is actually a good time.
That was planned anyway. You know, I didn’t want to be
limited because I am a single dad, and I run a business. So, it’s




Perceived recovery time and return to work were key concerns
across both trials. Both ACTIVE and PRESTO patients that we
interviewed had preferences for surgery due to a perceived
quicker recovery time.
“If anything had been quicker, I just wanted to get out of
there, there and then […] If anything had been quicker I
would’ve been like that, ‘Oh, do it. Get me out of here’, really”




Opinions and vicarious experiences of friends, relatives and other
non-professionals and patient’s own research influenced patient
decision making. In ACTIVE, people were influenced by others
that had received either treatment for other fractures.
“[My wife] was Googling everything up under the sun about it
for me as well and she came to the same decision as me. She
thought it was a good idea that I’d chosen that, the external
frame method because it just did seem like hacking into my




During ACTIVE, concerns about scarring from internal fixation
and how others may react to the external frame were prevalent.
Recruiters reported trying to address body image related
concerns by involving limb reconstruction nurses in recruitment
consultations, where possible
“I just couldn’t see how anybody could possibly live with this
barbaric contraption. It looks like a two-year old’s pedal bike





For the majority of patients, preferences were considered
changeable and examples of patients changing their mind were
provided. Trial recruiters dedicated part of recruitment
consultations to addressing this by discussing the pros and cons
of each treatment and tailoring information to the concerns of
individuals.
However, staff explained that there will always be a subset of
patients with strong, unchangeable preferences. Those which
based decisions on personal (e.g. children, fear) rather than
clinical reasons were considered particularly difficult to change.
Sometimes patients feel that they have expert knowledge of
their own body and so believe there must be a ‘best’ option for
any given individual. These patients often want to maintain
control of their own health and do not want others making
decisions for them.
Staff and patients provided examples of situations where
participation depended on allocation aligning with the
treatment preferences of patients. Some patients claimed they
would have withdrawn if they had not been randomised to
their preferred treatment.
“I said, oh I’m pretty much having surgery and he kind of
went “well no”. He took me through the options. So they
were very clear the way they described it and it was
interesting because there was a lot of debate because my
sister was there and my sister was calling my mother and my
sister and mother wanted me to have surgery because they
knew somebody who had a brace for scoliosis and said it was
extremely uncomfortable and their entire life, you know, the
period they were in a brace was pretty frustrating and so
yeah there was definitely….from the three members of the
medical team in the room and [name] was quite good at
arguing, not arguing, but basically giving the other opinions
to my sister and my mother who were kind of blasting me in
one ear.” (PRESTO patient interview, accepter).
Minimising risk of
randomisation
Some associate randomisation with a loss of autonomy. Both
patients and clinicians described how making patients aware
that clinicians have the final say in patient’s treatment and that
irrespective of their allocation they will receive the clinically
appropriate treatment was important along with emphasising a
patient’s right to withdraw.
In PRESTO, patients were informed they could switch treatments
“We are guided by the computer, purely because both the
treatment options are correct.” That makes them feel a little
bit more in control, like if you say that one is better than the
other, “Why am I being randomised then?” When you say to
them that both the options are pretty equal, then they are
happy and they know that there is always that opportunity to
cross over, because you do say to them that, “If during the
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in ACTIVE there was disagreement as to the definition
of an open fracture. Other factors which were perceived
to affect the number of eligible patients during PRESTO
included: difficulties obtaining consent and completing
study documentation for patients for whom English is
not their first language; mental health; frailty; patients
living in a different area to the treating hospital and so
wanting to be followed up locally and patients at high
risk of infection or of encountering wound problems and
wound breakdown. It was however suggested that staff
may be ‘hiding behind personal biases’ rather than
excluding patients for ‘objective reasons’. Despite having
screened approximately 80% of the predicted numbers of
patients overall in the PRESTO study, surgeons reported
that the target population was smaller than anticipated—
the majority of patients were either considered ‘very
stable’ or ‘very unstable’; therefore, far fewer patients met
the eligibility criteria than was predicted.
I guess, perhaps, that will be much more useful to
look at, at the end, when we see the trends really
clearly and you can say, “Well, okay, this was a huge
Table 5 Factors that patients consider when ‘weighing up’ their participation in a RCT (Continued)
Weighing up
Sub-theme Description Exemplar quote
if deemed clinically necessary during recruitment for those
allocated to surgery or follow-up for those allocated a brace.
In ACTIVE patients had been ‘put off’ participation by a
treatment being portrayed as more risky – this was perceived to
undermine equipoise by suggesting a surgeon feels one
treatment is better than another.
follow up process that we are treating you with a brace, if we
believe that things aren’t going in the right way, then trial, no
trial, we’ll switch you to whatever’s appropriate.” That is the
good thing that the patients recognise, that their treatment is
carrying on as it should be, whichever way the trial goes,
whether you go in the trial or you don’t go in the trial,
everything put together. I think that should reassure them
that we are more trying to treat them appropriately rather
than the trial. The trial comes second.” (PRESTO staff
interview).
Table 6 Key findings relating to trust
Trust




The majority of staff felt that recruitment should be a joint
venture involving a senior clinician and the research team to
instil confidence and trust in the trial and ensure patient
expectations are met.
Senior clinicians can build cases to support both treatments,
provide reassurance about them being routinely provided and
communicate the grey areas and complexities surrounding
treatment. Consultants were considered best placed to
challenge patients with strong preferences, particularly when
based on information received from clinicians in other
specialties.
Research staff are crucial for overcoming equipoise issues and
communicating study details as this is part of their daily role.
Patients were aware when recruiters did not appear
knowledgeable about interventions.
Avoiding key terminology was perceived to cause uncertainty
and undermine confidence and trust.
“The pros are that the clinician has a very in-depth understand-
ing and is used to presenting information about those two
treatment options. In think the negative, sometimes can be in
relation to knowledge of how a research trial works and the
potential pitfalls of presenting information in a certain way that
might lead the patient one way or the other, and how careful
we need to be with that. Also, to make the patient feel very
much not under pressure to join the trial. I think that’s some-
thing that, perhaps the research team is a bit better at, having
more experience in that area, So I think there are pros and
cons, and that obviously is clinician dependent and research
team member dependent. Certainly what we found worked
really well here, was to have the clinician present the clinical
parts of it so that the patient knows that the clinical informa-
tion is coming from a clinician who would be treating them.
Then for the research team to explain participation, withdrawal
procedures and all that kind of stuff.” (PRESTO staff interview)
Practicalities of
‘joint’ consultations
Time constraints, concerns about surgeon equipoise and
availability meant the practicalities of involving surgeons and
research staff at the same time at all consultations is
challenging. To overcome this, at some sites, surgeons and
research staff held separate conversations with patients about
treatments and the study respectively.
“So I speak to them first. I tell them what it entails if they’re
interested to be involved in the trial. If they are interested then
I will let the research nurse know, who will also go through all
the details of the trial.” (PRESTO staff interview)
Engagement of
clinical teams
The central role of clinical teams in recruitment and checking
whether patients are eligible means ensuring their continuous
engagement is crucial in surgical trials.
PRESTO staff were concerned that PIs would lose enthusiasm
over time and that reduced engagement could negatively
affect recruitment.
“It was to be a study that lasts a long time and there can be
periods where there’s not much recruitment, the concern is
then that people get a bit bored and disengaged with it, and I
think that’s a little but what’s happened to be honest. And I
think if there was a trial that was going on for four, five years,
by this point, people had already started to lose interest.” (PRES
TO staff interview)
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number of people we excluded for this reason. Was
that actually justified, in terms of the science that we
have out there at the moment, to say, “This group of
patients should have been managed as they were,
and excluded”? (PRESTO, staff interview)
Discussion
This paper reports the findings of two qualitative studies
that were conducted during a large, multi-centre, UK-
wide RCT’s internal pilot phase (ACTIVE) and a mixed
methods feasibility study’s (PRESTO) recruitment period.
We used a recent mixed methods review of patients’ ex-
periences of being recruited to surgical trials as a frame-
work for reporting our findings [1]. Our data mapped
onto the key themes identified by Phelps [1] and suggest
that a patient’s decision to take part in a RCT is deter-
mined by how they can ‘make sense’ of the trial and the
impact of participation on patient care and daily life; a
process of ‘weighing up’ where patients trade off the risks
and benefits associated with participation and ‘trust’ in
the treating clinicians and the research team.
We also identified two additional factors that affect
recruitment, which are not reported by Phelps—the
impact of patient pathways and how eligibility criteria
are interpreted and applied by clinical staff [1]. Al-
though recognised as barriers to trial recruitment [10,
11, 15], they have been given less attention in the re-
cruitment optimisation literature than factors such as
equipoise, randomisation and communication. The
relative lack of attention paid to patient pathways may
in part be due to the differential impact this will have
across trials. The complexity of patient pathways will
vary according to the surgical area of interest and is
likely to be site specific. Some approaches to address-
ing the issues would potentially require a large invest-
ment of resources for both trials units and site staff.
For example, many of the strategies for addressing is-
sues arising from complex patient pathways that we
propose in Table 7 would require trial recruiters to
ensure that staff from multiple specialties are aware of
a trial and are prepared to support the identification
and recruitment of patients throughout a trial’s re-
cruitment period. The complexities of this should not
Table 7 Involving multiple specialties in recruitment to future orthopaedic surgical trials
Suggestion for involving multiple specialties in the recruitment of patients to future orthopaedic RCTs
Encourage inter-specialty collaboration through associate prin-
cipal investigators (PIs)
Appointing clinical trainees as associate PIs may encourage inter-specialty collabor-
ation, optimise recruitment and provide study support. Trial teams should provide
manuals to support associate PIs and encourage professional benefits to individuals
for adopting these roles such as Continuing Professional Development (CPD) (AC-
TIVE, PRESTO)
Name clinicians from specialties not involved in recruitment on
delegation logs.
Ensuring surgeons from other key specialties and particularly registrars are on
delegation logs to ‘intercept the pathway’ and account for the fact that treatment
decisions are often made quickly. (PRESTO)
Raise awareness of trials through regular presentations and
posters at trial sites.
To account for staffing changes and junior doctor rotation, regular presentations and
briefings about studies that are open for recruitment are important. (PRESTO) Trial
teams should distribute posters to study sites for display in all departments where
potentially eligible patients are assessed and/or admitted. (ACTIVE)
Use technology to encourage communication between clinical
and research teams.
Creating a WhatsApp group for clinical and research staff to improve
communication and ensure that patients are approached to take part in studies as
soon as is appropriate after admission. (PRESTO)
Provide opportunities for research staff to discuss potentially
eligible patients.
Research staff attending handover meetings in person or receiving daily handovers
from specialties involved in recruitment is important to ensure no potentially eligible
patients are missed. (PRESTO)
Encourage the involvement of on-call staff in recruitment Ensure on-call staff are aware of study recruitment criteria and have access to the
study team’s contact details (ACTIVE)
Ensure mechanisms for communication between key
specialties and PIs at trial sites are established and known.
Asking specialties to directly call the PI or study team as soon as a patient is
identified, so they can be screened and an appointment arranged immediately.
(PRESTO)
Involve the Emergency Department (ED) in recruitment Involving ED staff in recruitment and ensuring ED is being screened daily is
important to avoid missing potentially eligible patients. Out of hours support for
research staff, is particularly important for units that ‘encroach on ED’ to
accommodate for out of hours admissions. Having an open clinic for patients to be
booked into from ED may be of benefit. (PRESTO)
Use electronic systems where possible to identify eligible
patients
Sites should consider searching electronic systems where these are available to
identify all eligible patients (ACTIVE)
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be underestimated, particularly when considering: the
implications of staff turnover and part-time workers;
the number of sites and specialties that can be in-
volved in recruitment, particularly in large national
trials such as ACTIVE (n= 30), the difficulties of bal-
ancing recruitment against routine clinical work; and
the number of RCTs and research studies that can be
on-going at any given site. In addition to these prac-
tical issues, problems with equipoise and the strong
and divided opinions of clinicians around current
treatment often underpinned many of the problems
we identified with patient pathways and operationalis-
ing eligibility criteria.
During PRESTO, despite trial recruiters using well
established and routinely used methods for determin-
ing whether a patient has capacity to provide in-
formed consent, some PRESTO patients perceived
themselves to lack capacity at the time of recruit-
ment. The discrepancy between how staff and pa-
tients perceived the informed consent process during
the PRESTO trial suggests that current methods for
establishing capacity may need to be improved. This
finding speaks to a larger ongoing discussion relating
to the consent process in research. Much of this dis-
cussion has focussed on moving away from our
current emphasis on a single moment of consent to
an ongoing consent dialogue with research partici-
pants [16, 17]. However, this is difficult to achieve in
clinical practice and has significant implications for
how we currently approach consent within trials as it
would require all stakeholders (including researchers
and ethics committees) to adapt to what might po-
tentially become a less well-defined process. The
CONSULT study [18] is an on-going NIHR funded
study which is focussed on improving the inclusion
of adults lacking capacity in research through a deci-
sion support intervention to help family members to
make decisions about research. Whilst this could
equally be applied to potential trial participants for
whom lack of capacity is transient, it is not the only
solution. A collective effort is required to develop
multiple strategies and/or interventions to improve
and optimise consent processes which consider the
needs of different populations and contexts.
The mixed methods systematic review conducted by
Phelps and a recent Cochrane qualitative evidence
synthesis provide two comprehensive evaluations of
the evidence on factors affecting recruitment to RCTs
from the perspective of trial participants [1, 15].
When combined with our findings, which incorpo-
rated the perspective of both patients and trial re-
cruiters, it is clear that the same issues relating to
equipoise, how randomisation is communicated and
the impact of patient preferences are repeatedly
reported as barriers to recruitment across a range of
RCTs. It could therefore be argued that we have
reached a saturation point of evidence exploring bar-
riers and facilitators to trial recruitment. We do not
dispute the value of including recruitment optimisa-
tion interventions within RCTs, especially bespoke so-
lutions which target trial and site-specific issues in
detail, e.g. QuinteT (Qualitative research integrated
within trials) [19–21]. However, we suggest that future
work focusses on ensuring that existing evidence is
disseminated, applied and used to inform the design
of process evaluations and recruitment to future RCTs
if we are to avoid further research waste [22]. More
specifically, there is a need for trials units to ‘lead by
example’ and ensure that their staff are up to date on
the current evidence on recruitment optimisation and
directly apply this to site set-up, development of trial
documentation (e.g. participant information sheets),
trial design and recruitment. Training such as ‘Gran-
ule’ [23] should be completed by all those involved in
recruitment and research teams to maximise the effi-
ciency of site initiation visits and to ensure that study
documentation and recruitment consultations are in
line with the latest evidence. Lastly, developing
methods that apply existing evidence, but require
minimal resources, should be a methodological prior-
ity if we are to make use of the existing evidence base
and optimise recruitment to future trials.
Strengths and limitations
We used a recent mixed methods systematic review
[1] as a framework for reporting our findings, which
has enabled us to go beyond a descriptive account
and place our findings in the context of existing evi-
dence. Our findings are based on data that was col-
lected from patients who agreed and declined to
participate in a trial and the views of surgeons and
trial recruiters. This enabled us to obtain a more de-
tailed understanding of the complexities surrounding
trial recruitment than would have been possible had
we have only explored this issue from the perspective
of one stakeholder group. Trial recruiters across both
studies expressed uncertainties surrounding the appro-
priateness of interviewing patient decliners despite this
being established practice. In the ACTIVE study, we
were able to mitigate against this and provide reassur-
ance through site initiation visits and additional, sep-
arate follow up phone calls with sites about the
qualitative study and this may account for the dis-
crepancy in recruitment of patient decliners between
the two trials. As such, we would recommend under-
taking this additional preliminary work when design-
ing future process evaluations.
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Conclusion
This study has highlighted the challenges of recruiting
patients to RCTs. In this paper, we presented findings
from two qualitative process evaluations, which were
conducted to inform recruitment to two orthopaedic
surgical trials. When considering our findings and those
of two recent systematic reviews of the evidence on re-
cruitment to RCTs, we argue that a shift is required in
how process evaluations are conducted. We suggest that
to optimise recruitment, the wealth of knowledge that
has been accumulated is used to inform recruitment and
that priority is given to developing less resource-
intensive interventions, which use existing evidence to
optimise recruitment.
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